Larson Financial Group
XGN icon

Larson Financial Group’s Exagen XGN Stock Holding History

Larson Financial Group’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,843
Closed -$11.2K – 3804
2025
Q4 		$11.2K Sell
1,843
-7,670
-81% -$69.8K ﹤0.01% 2052
2025
Q3 		$105K Buy
+9,513
New +$84.3K ﹤0.01% 884

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Silvercrest Asset Management
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Larson Financial Group's XGN Position: Q1 2026 in Review

Larson Financial Group sold out of Exagen (XGN) in Q1 2026, closing a stake of 1,843 shares — an estimated $11.2K sold.

Larson Financial Group first reported a position in XGN in Q3 2025 and held it in 2 quarters. The position peaked at $105K in Q3 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Larson Financial Group reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • Larson Financial Group sold 1,843 Exagen shares in Q1 2026, an estimated $11.2K.
  • Larson Financial Group first reported a position in Exagen in Q3 2025 and held it in 2 quarters.
  • Larson Financial Group's Exagen position peaked at $105K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.